Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
5.90
-0.26 (-4.22%)
May 9, 2025, 10:56 AM - Market open
Exagen Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Exagen stock have an average target of 7.50, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 27.12% from the current stock price of 5.90.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 13, 2025.
Analyst Ratings
The average analyst rating for Exagen stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | +35.59% | Jan 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +18.64% | Jan 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +18.64% | May 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +1.69% | Sep 26, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +1.69% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
65.19M
from 55.64M
Increased by 17.16%
Revenue Next Year
75.68M
from 65.19M
Increased by 16.10%
EPS This Year
-0.57
from -0.83
EPS Next Year
-0.27
from -0.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 69.4M | 81.5M | 89.0M | ||
| Avg | 65.2M | 75.7M | 85.6M | ||
| Low | 62.6M | 71.5M | 83.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.7% | 25.0% | 17.6% | ||
| Avg | 17.2% | 16.1% | 13.2% | ||
| Low | 12.5% | 9.7% | 9.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.56 | -0.08 | -0.19 | ||
| Avg | -0.57 | -0.27 | -0.18 | ||
| Low | -0.60 | -0.37 | -0.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.